Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a volatile pharmaceutical market. The transaction, involving 700 million ...

adding that about 85% of the products Haleon sells in the country are manufactured in its plants in Tianjin and Suzhou, Jiangsu province. Noting China’s recent policy measures to remove all ...

GSK’s consumer health spinout Haleon has acquired exclusive US rights to commercialise the gel-based product, called MED3000, in return for an initial upfront payment of $4 million, milestone ...

The UK pharma group – now a therapeutics and vaccines pure-play since the spin-off of Haleon in July – also raised its financial forecasts for the full year for the second time in consecutive ...

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading ...

Shares of HLN opened at $10.45 on Wednesday. Haleon has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a 50-day moving average price of $9.66 and a two-hundred day moving ...

Pfizer sells entire Haleon stake for $3.24 billion Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer ...

(Bloomberg) -- Pfizer Inc. plans to sell about £2 billion ($2.5 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce its 32% stake.